Physician profile
Gray Allen Bailey
NPI 1265561344
$1,037.50
in general payments reported to CMS, 2019-2025
10 companies · $212 in 2025
The $212 reported for 2025 was more than what 77% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $161 · 2021: $27.27 · 2022: $30.00 · 2023: $471 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.33 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carestream Dental, LLC | $336.91 | 2019-2023 | |
| Zimvie INC. | $180.73 | 2025 | |
| Dentsply Sirona INC | $136.49 | 2019-2023 | Cerec, Cavitron |
| Ivoclar Vivadent, INC. | $124.14 | 2020 | |
| Biohorizons Implant Systems INC. | $97.24 | 2023 | Biohorizons |
| Nobel Biocare USA | $53.11 | 2023 | Nobelactive |
| Kerr Corporation | $53.10 | 2023 | Endodontics |
| Patterson Companies, INC. | $25.00 | 2020 | |
| Hu-Friedy Mfg. Co., LLC | $15.73 | 2025 | Ims |
| Colgate Oral Pharmaceuticals, INC. | $15.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gray Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.